New research published in Nature Communications shows how generative AI can be used to design complex dual-action cancer drug ...
A Duke Health-led consortium has achieved key preclinical milestones in developing regenerative therapies that target ...
International researchers have mapped the structure of the thromboxase A₂ receptor using cryo-electron microscopy, revealing some unexpected activation mechanisms.
New research from Shanghai Pulmonary Hospital outlines how lactate-driven lactylation acts as a metabolic switch controlling ...
Insilico Medicine has nominated ISM6200, a preclinical drug candidate designed using generative AI to target NR3C1, a receptor involved in cortisol regulation.
Oregon State University researchers have developed engineered lipid nanoparticles that deliver follistatin mRNA directly to ...
Novel FRESH 3D printing technology enables fabrication of nanoscale spanlastic carriers for localised anticancer drug delivery. Early in vitro studies have demonstrated enhanced cellular uptake and ...
AI is accelerating drug discovery at an unprecedented pace. Thousands of antibody candidates can now be designed in silico ...
Promatix Biosciences is developing a new generation of bispecific antibody-drug conjugates using proprietary membrane ...
NAMs are now part of early drug discovery, but adoption remains uneven. Join leading experts for a discussion on current ...
A new study has revealed that age-related clonal haematopoiesis accelerates aortic aneurysm growth through RANK/RANKL signalling, meaning that repurposing osteoporosis drugs targeting this pathway ...
ELRIG is launching its first major US event, Drug Discovery USA 2026, at Pfizer’s Cambridge, Massachusetts facility on 16–17 June. The free-to-attend conference will bring together European and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results